John Hopkins University
1101 East 33rd Street
Baltimore, Maryland 21287
Baltimore, Maryland 21287
We've found
9 trials
at this facility
Non-small Cell Lung Cancer Stage IV Clinical Trial
Updated: 3/10/2016
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Enrolling,
Phase
II
Updated: 3/10/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/2/2016
Immunotherapy Study for Metastatic Renal Cell Cancer
Status: Enrolling,
Phase
I
Updated: 2/2/2016
Click here to add this to my saved trials
Neurology Clinical Trial
Updated: 12/31/1969
Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Disease Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Huntington's Disease Clinical Trial
Updated: 12/31/1969
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Parkinson Disease Clinical Trial
Updated: 8/7/2017
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Status: Enrolling,
Phase
II
Updated: 8/7/2017
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Characteristics That Modify the Response to Cholecalciferol Treatment Clinical Trial
Updated: 12/31/1969
Individualized Response to Vitamin D Treatment Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials